Sun Pharma Advanced Research Company Ltd (SPARC) on Tuesday, December 17, said it has signed a binding Letter of Intent (LoI) with the University of California, San Francisco (UCSF) and Tiller ...

The LOI outlines the key terms of license and rights for development and commercialization by Tiller. Under the terms of the LOI, SPARC will receive a 55% equity stake in Tiller upon execution of LOI.

Shares of Sun Pharma Advanced Research (SPARC) are higher by more than 13% on December 16, after the management said it plans to share an 'update' on its clinical programs as well as the R&D ...